EP Patent

EP2790670A1 — Gel compositions

Assigned to Leo Laboratories Ltd · Expires 2014-10-22 · 12y expired

What this patent protects

The present invention relates to a topical gel composition comprising ingenol-3-angelate,wherein the composition provides greater flux, according to the in vitro diffusion test, of ingenol-3-angelate into the stratum corneum, epidermis and dermis after application of the gel co…

USPTO Abstract

The present invention relates to a topical gel composition comprising ingenol-3-angelate,wherein the composition provides greater flux, according to the in vitro diffusion test, of ingenol-3-angelate into the stratum corneum, epidermis and dermis after application of the gel composition to skin than does a reference gel of ingenol-3-angelate, namely the PICATO® product.

Drugs covered by this patent

Patent Metadata

Patent number
EP2790670A1
Jurisdiction
EP
Classification
—
Expires
2014-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Leo Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.